KAROLINSKA INSTITUTET
- Country
- Sweden
- Type
- Beneficiary
- Website
- www.ki.se
- Grants received
- 701
Funding record
- 701 grants on record
- €463,574,152.02 awarded in total
- 2008–2026 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Seventh Framework Programme
- Horizon Europe Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
296 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE
- HELSINGIN YLIOPISTO
- KING'S COLLEGE LONDON
- KOBENHAVNS UNIVERSITET
Calls from this organisation
No published calls from this organisation.
Grants received
- Partial reprogramming for hematopoietic system rejuvenation: Impact on systemic hallmarks of aging and health span
- Boosting future REsearchers in biomaterials for Advanced healTH solutions
- Unveiling the role of histone marks in metabolic memory storage and transmission.
- SpatioTemporal Diversification of Enteric Nervous system
- Habenula molecular and functional Organization in models of Pathological Emotional States
- Prediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on fertility and gonadal toxicity
- Direct in utero engineering of mouse models
- Global-Ig: a population-based antibody library technique to optimize the development of globally protective vaccines
- Tight junctions and tissue mechanics as sensors and executers of heart regeneration
- Characterisation and design of RNA-lipid interactions for RNA therapeutics
- Nanoparticle-mediated ocular delivery of novel NAD-boosting small molecules for ophthalmic disease.
- NEW TECHNOLOGY FOR 1 MICRON RESOLUTION BIOMEDICAL IMAGING
- Virus related biomarkers to improve management of chronic conditions
- Comparative signature of Marburg virus cell activation as a blueprint for the identification of antiviral targets against newly emerging viruses
- UnderstandiNg fraIlty tOwards a future of healthy ageiNg
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.